# OnCo record philippe-armand (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/philippe-armand/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "philippe-armand" ;
  schema:name "Philippe Armand"@en ;
  schema:description "Boston lymphoma doctor who led KEYNOTE-170, the trial that showed pembrolizumab can control relapsed primary mediastinal B-cell lymphoma, and who helped bring PD-1 blockade to Hodgkin lymphoma."@en ;
  schema:url <https://onco.cc/people/philippe-armand/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "lymphoma", "immunotherapy", "trialist" ;
  schema:jobTitle "Lymphoma specialist, Dana-Farber Cancer Institute" ;
  onco:cancers <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-170-pembrolizumab-pmbcl-armand-jco-2019/> ;
  schema:affiliation <https://onco.cc/institutions/dana-farber/> .